INFECTION TRANSMISSION RISK AND DIFFERENT TEST STRATEGIES
SCREENING AND CONFIRMATORY TESTING STRATEGIES FOR TRANSFUSION-TRANSMISSIBLE VIRAL INFECTIONS
INFECTIVITY OF HBV AND THE SCREENING STRATEGY
MEETING CLINICAL DEMAND FOR BLOOD AND BLOOD PRODUCTS
UNDERSTANDING THE CURRENT AND FUTURE DONORS: FOCUSING ON THE KOREAN SITUATION
DONOR SELECTION FOR BLOOD SAFETY: IS IT STILL NECESSARY?
CURRENT PERSPECTIVES IN TRANSFUSION-TRANSMITTED INFECTIOUS DISEASES: EMERGING AND RE-EMERGING INFECTIONS
BACTERIAL CONTAMINATION
PATHOGEN REDUCTION TECHNOLOGY
1B-H4–01
HOW TO GET YOUR ABSTRACT ACCEPTED AND HOW TO PRESENT IT
HOW TO GET A PAPER PUBLISHED
INTRODUCING THE ISBT GUIDELINES, STANDARDS AND REGULATIONS REPOSITORY
THE DEVELOPMENT OF STEP WISE ACCREDITATION FROM THE AFRICA SOCIETY PERSPECTIVE
MONITORING TRANSFUSION PRACTICE
DETERMING LOCAL POPULATION FREQUENCIES USING GENETIC TECHNIQUES
DIAGNOSIS AND TREATMENT OF AUTOIMMUNE HAEMOLYTIC ANAEMIA
CASE STUDIES - RESOLVING COMPLEX SEROLOGICAL PROBLEMS
HAEMOVIGILANCE: CONCEPTS AND FRAMEWORKS
DEFINITIONS IN HAEMOVIGILANCE
TRACEABILITY AND THE USE OF UNIQUE IDENTIFIERS
THE IMPORTANCE OF PLATELET ANTIGENS AND ANTIBODIES IN IMMUNE MEDIATED THROMBOCYTOPENIA
DETECTION OF CLINICAL RELEVANT PLATELET ANTIBODIES IN THE ASIAN POPULATION
GENETIC POLYMORPHISMS OF HUMAN PLATELET ANTIGENS (HPA) IN THE ASIAN POPULATION: IMPLICATIONS IN ESTABLISHMENT OF PLATELET DONOR REGISTRIES
SETTING UP A PATIENT BLOOD MANAGEMENT PROGRAMME
APPLYING MASSIVE TRANSFUSION PROTOCOLS IN TRAUMA
RH D ALLOIMMUNIZATION AFTER TRANSFUSION OF D+ PLATELETS IN D - PATIENTS. IS RH IMMUNOGLOBULIN PROPHYLAXIS INDICATED?
AN AUDIT OF TRANSFUSION PROCESS: AN IMPORTANT TOOL FOR TRANSFUSION SAFETY
MALDI-TOF MS BASED BLOOD GROUP GENOTYPING - PROGRESS OF AN ALTERNATIVE APPROACH
GP.KIPP AND GP.YAK BAB HYBRID GLYCOPHORINS: NO DIFFERENCE IN SEQUENCE OR SEROLOGY
MOLECULAR GENOTYPING OR SEROLOGICAL PHENOTYPING, WHICH IS MORE COST-EFFECTIVE
IDENTIFICATION OF BLOOD GROUP SINGLE NUCLEOTIDE POLYMORPHISMS BY 5—NUCLEASE ASSAY FOR ESTABLISHMENT OF AN ANTIGEN NEGATIVE RED BLOOD CELL INVENTORY AND BLOOD DONOR POOL
EXTENDED ERYTHROCYTE TYPING: MOLECULAR TECHNIQUE VS SEROLOGICAL TECHNIQUE
PATHOGEN INACTIVATION - ARE WE THERE YET?
EFFICIENT INHIBITION OF MITOCHONDRIAL DNA AMPLIFICATION USING A REAL-TIME PCR ASSAY AFTER TREATMENT WITH THE INTERCEPT SYSTEM FOR PATHOGEN INACTIVATION
PATHOGEN REDUCTION TREATMENT AND SUBSEQUENT STORAGE OF BUFFY-COAT DERIVED PLATELETS ALTERS PRODUCTION OF MONOCYTE INFLAMMATORY MEDIATORS IN A WHOLE BLOOD TRANSFUSION MODEL
THE COMPARISON OF HCV SUBTYPES BETWEEN CLINICAL PATIENTS AND BLOOD DONORS IN GUANGDONG CHINA
DETECTION OF HEPATITIS B VIRUS FROM SERA OF TRANSFUSED PATIENTS IS NOT ALWAYS DUE TO BLOOD TRANSFUSION
THE MYTHS OF BLOOD GROUPS
FIVE NEW BLOOD GROUPS - WHAT NEXT?
EMERGING AND IMPORTED INFECTIONS IN THE REGION - WHAT's BOTHERING US TODAY?
VIRAL TRANSMISSION RISK ASSESSMENT ON INDIVIDUALDONATION NUCLEIC ACID TESTING IN KUALA LUMPUR, MALAYSIA
TRANSFUSION TRANSMITTED HEPATITS A INFECTION CASES IN KOREA
PREVALENCE OF PREVIOUS INFECTION WITH HEPATITIS A, B AND E IN BLOOD DONORS IN THE WESTERN CAPE, SOUTH AFRICA
DISTRIBUTION OF HEPATOCELLULAR CARCINOMA-RELATED (HCC) MUTATIONS AND DRUG RESISTANCE RELATED MUTATIONS OF HBV IN CHINESE BLOOD DONORS
A FRESH LOOK AT MEASURING QUALITY IN BLOOD COMPONENTS
RESIDUAL PLATELETS POTENTIATE RELEASE OF PROCOAGULANT AND PROINFLAMMTORY RED CELL MICROPARTICLES (RMP) DURING BLOOD STORAGE
PLATELET DERIVED MICROPARTICLES INDUCE POLYMORPHONUCLEAR LEUKOCYTES MEDIATED DAMAGE OF HUMAN PULMONARY MICROVASCULAR ENDOTHELIAL CELLS
FREQUENT PLATELETPHERESIS DONATION INCREASED PLASMA LEVELS OF P-SELECTIN IN HEALTHY DONORS
WASHING OF RED CELLS, AGE AT THE TIME OF PROCESSING AND SUBSEQUENT STORAGE INFLUENCE THE IN VITRO QUALITY AND BIOACTIVE SUBSTANCES IN THE RED CELL SUPERNATANT
BIOBANKING
HOW TO ESTABLISH AND RUN A CELL THERAPY UNIT IN A BLOOD BANK
HOW TO PREPARE YOUR CELL THERAPY UNIT FOR ACCREDITATION
NEW APPROACHES TOWARDS MANUFACTURE OF PLASMA DERIVATIVES
IS THERE ANY ROLE FOR HYPERIMMUNE PLASMA IN PANDEMIC SITUATIONS?
EVALUATION OF NEUTRALIZING ACTIVITY OF PLASMA OBTAINED FROM JAPANESE INDIVIDUALS AGAINST MOSQUITO-MEDIATED VIRAL INFECTIONS: USING INTRAVENOUS IMMUNOGLOBULIN
ASSESSMENT OF THE IN VITRO ANTI-INFLAMMATORY ACTIVITY OF PLASMA/PLATELET FRACTIONS USED IN REGENERATIVE MEDICINE
DEFINING AND FINDING THE RARE DONOR
ESSENTIALS OF A NATIONAL RARE DONOR REGISTRY
THE FIRST EXAMPLE OF AN ACUTE HEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-EMM AND THE FIRST JAPANESE PROBAND
NEW APPROACHES TO WIDEN THE DONOR BASE THROUGH CHANGING THE BLOOD DONATION CULTURE: FOCUSING ON THE CASES IN KOREA
UNDERSTANDING THE PSYCHOLOGY OF BLOOD DONATION
SUCCESSFUL MODELING OF DONATION PREFERENCE INTO NEW COLLECTION SITE TO MEET DONORS’ EXPECTATION AND BLOOD DEMAND
THE BENEFIT OF RESEARCH IN ENSURING SUCCESS OF A NEW BLOOD COLLECTION CENTRE
SETTING UP HAEMOVIGILANCE PROGRAMME FROM THE VERY FIRST STEP
HAPTOGLOBIN DEFICIENCY AMONG PATIENTS WITH NONHEMOLYTIC TRANSFUSION REACTIONS, A FIFTEENYEAR SURVEY IN JAPAN
‘REDUCING ERRORS IN BLOOD SPECIMENS’ A TERTIARY CARE HOSPITAL INITIATIVE
HAEMOVIGILANCE: 10 YEARS EXPERIENCE IN MALAYSIA (2003-2012)
AN INSIGHT INTO ERRORS IN THE TRANSFUSION CHAIN: 5 YEAR EXPERIENCE AT A HOSPITAL BASED TRANSFUSION CENTRE
CAN WE MANAGE BLOOD INVENTORY EFFECTIVELY
ADOPTING A PROACTIVE APPROACH TO BLOOD SHORTAGES
MONITORING AND EVALUATING THE EFFECTIVENESS OF INTERVENTIONS AGAINST CROSS-MATCH TO TRANSFUSION RATIO (C/T RATIO) FOR MAJOR DEPARTMENTS IN KUALA LUMPUR HOSPITAL FROM YEAR 2005 TO YEAR 2012
THE IMPACT OF OPTIMIZED RED CELL SHELF-LIFE ON BLOOD UTILIZATION OF CHRONICALLY TRANSFUSED PATIENTS-BUMP STUDY
3A-S12–01
COMBINATION OF AUTOLOGOUS PLATELET GEL AND SKIN GRAFT TO TREAT NON-HEALING DIABETIC LOWER EXTREMITY ULCERS
ISOLATION AND EX VIVO PROPAGATION OF CORNEAL ENDOTHELIAL CELLS IN A XENOGENEIC-FREE AND RECOMBINANT GROWTH FACTOR-FREE MEDIUM SUPPLEMENTED SOLELY WITH HUMAN PLATELET LYSATE
THE IMMUNE SYSTEM AS SEEN THROUGH THE EYES OF A PLATELET
NEW IMMUNE ROLE OF PLATELETS IN MALARIA
HEPARIN-INDUCED THROMBOCYTOPENIA IN JAPAN
AUTOIMMUNE THROMBOCYTOPENIA - NEW MECHANISMS AND THEIR RELEVANCE IN DIAGNOSIS AND TREATMENT
CLINICAL IMPACT OF PLATELET TRANSFUSION ON THROMBOEMBOLISM IN PATIENTS WITH ACUTE HEPARININDUCED THROMBOCYTOPENIA
AN EVALUATION OF TRANSFUSION RESPONSE IN PLATELET TRANSFUSION REFRACTORINESS USING PLATELET DONOR REGISTRY IN SHANGHAI
THE CLINICAL IMPACT OF ANTIBODIES AGAINST CD36 IN SOUTH CHINA
DO WE REALLY NEED FFP? THE EVOLVING ROLE OF PF24 AND PRE-THAWED PLASMA
SOURCING CLINICAL PLASMA FROM MALE ONLY DONORS IN AUSTRALIA
LOWER RATE OF ADVERSE EVENTS WITH METHYLENE-BLUE TREATED PLASMA COMPARED WITH QUARANTINE STORED PLASMA
QUALITY OF PATHOGEN AND LEUKOCYTE INACTIVATED RBC COMPARED TO CONVENTIONAL AND GAMMA IRRADIATED RBC
PREPARATION OF POOLED BUFFY-COAT PATHOGEN REDUCTION-TREATED PLATELET CONCENTRATES IN PLATELET ADDITIVE SOLUTION USING TOP AND BOTTOM METHOD
CURRENT ISSUES IN DONOR HEALTH AND SAFETY
DONOR VIGILANCE - A GLOBAL UPDATE
DEMOGRAPHIC PROFILE OF HIV DONORS WHO DONATED DURING THE SEROLOGICAL WINDOW PERIOD
A NATIONWIDE SURVEY ON KNOWLEDGE, ATTITUDE AND PRACTICES TOWARDS BLOOD DONATION IN PAKISTAN
MANAGING THE PLATELET REFRACTORY PATIENT
MANAGING BLEEDING IN CARDIAC SURGERY
UNDERLYING PRECIPITANTS DO NOT INFLUENCE CLINICAL PRESENTATION OR THERAPY FOR TTP: DATA FROM THE AUSTRALIAN REGISTRY
INTRAOPERATIVE BLOOD REQUIREMENTS DURING LIVING DONOR LIVER TRANSPLANTATION IN PEDIATRIC RECIPIENTS
ADVANCES IN GRANULOCYTE TEST METHODOLOGIES
ITS NOT JUST ABOUT TRALI - THE CLINICAL SIGNIFICANCE OF NEUTROPHILS
TRALI: CHARACTERIZATION OF LEUCOCYTE ALLOANTIBODIES IN FEMALE VOLUNTEER BLOOD DONORS IN CHINA
POLYMORPHIC HUMAN NEUTROPHIL ANTIGENS IN ETHNIC NORTHEAST THAIS
CHANGES TO ISBT 128 CELLULAR THERAPY TERMINOLOGY
SUCCESSFUL TREATMENT OF THERAPY-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE WITH MESENCHYMAL STEM CELL-DERIVED EXOSOMES
EVALUATION OF IMMUNOMODULATORY EFFECT OF MESENCHYMAL STEM CELLS ON MICE DENDRITIC CELLS MATURATION AND T-CELLS FUNCTION
MYELOID ZINC FINGER-1 (MZF-1) TRANSCRIPTIONALLY REGULATES CCN2 AND CCN3 IN THE HEMATOPOIETIC COMPARTMENT, WITH IMPORTANT IMPLICATIONS FOR BLOOD AND BONE MARROW DONATION
EFFECTIVE THERAPY BY TRANSFUSING TGF-BETA-INDUCED FOXP3+ REGULATORY T CELLS EXPANDED BY TOLOREGENIC DENDRITIC CELLS IN THE MODEL OF AUTOIMMUNE ARTHRITIS
SELF-SUFFICIENCY IN PDMP BASED ON VNRBD - AN ACHIEVABLE GOAL?
MANAGING A BLOOD PROGRAM WITH LIMITED RESOURCES IN NEPAL
STEPWISE IMPLEMENTATION OF THE NATIONAL BLOOD PROGRAM IN CAMBODIA: A PARTNERSHIP APPROACH
HEALTH ECONOMIC ANALYSIS OF NUCLEIC ACID TECHNOLOGY TESTING IN INDONESIA
CURRENT EPIDEMIOLOGY AND CLINICAL PRACTICE IN ARBOVIRAL INFECTIONS - IMPLICATIONS ON BLOOD SUPPLY IN THE REGION
RISK REDUCTION STRATEGIES FOR TRANSFUSIONTRANSMISSIBLE ARBOVIRAL INFECTIONS
PREVALENCE OF SYMPTOMATIC DENGUE VIRUS INFECTION IN TRANSFUSED PATIENTS
ANTI-TRYPANOSOMA CRUZI TEST AND QUESTIONNAIRE SURVEY IN JAPAN FOR BLOOD DONORS NATIVE OF LATIN AMERICA
INFECTIOUS RISKS: THE APPROACH TO RISK ESTIMATION AND SURVEILLANCE
TRANSFUSION SAFETY IN THE HOSPITAL
WHATS NEW WITH TRALI?
P-001
UNITED NATIONS UN3373 TRANSPORTATION OF DIAGNOSTIC SAMPLES
LESOTHO BLOOD TRANSFUSION SERVICE: TRANSITION FROM PAPER BASE TO A BLOOD ESTABLISHMENT COMPUTERIZED SYSTEM
CENTRALIZED NETWORK MANAGENT IN BLOOD TRANSFUSION SERVICE: CASE OF RWANDA
BECS BACKUP AND RETRIEVAL: CASE OF RWANDA
BEGINNING KNOWLEDGE OF TRANSFUSION IN JAPAN
PROCESING AND TESTING PRODUCTIVITY
PROCESS IMPROVEMENT ON EQUIPMENT CALIBRATION IN HKRCBTS QUALITY CONTROL LABORATORY USING QUALITY TOOLS OF LEAN MANUFACTURING
INTEGRATION LEAN THINKING INTO A CLINICAL LABORATORY AND WORKFLOW IMPROVEMENT
A PILOT STUDY FOR AN EVALUATION OF RAPID BLOOD GROUPING CARDS FOR PATIENTS AND BLOOD DONORS
TRAINING IN CLINCAL RESEARCH RELEVANT TO INTERNATIONAL TRANSFUSION SAFETY: A 9-YEAR PROGRESS REPORT
EXPERIENCE OF CONDUCTING THE FIRST EVALUATION OF SPECIALIST IN BLOOD BANK TECHNOLOGY BY TAIWAN SOCIETY OF LABORATORY MEDICINE
P-013
PRACTICAL GUIDE TO PREVENT TRANSFUSION ERRORS IN HOSPITALS
ESTABLISHMENT OF THE COLLEGE OF TRANSFUSION NURSES IN JAPAN
TRANSFUSION MEDICINE KNOWLEDGE AND ATTITUDES AMONG GENERAL PHYSICIAN AND RESIDENTS STUDENTS
WORKING TOWARDS COMPLIANCE WITH NEW IN VITRO DIAGNOSTIC MEDICAL DEVICE REGULATIONS IN AUSTRALIA
EFFECT OF FIRST-TIME DONORS ON INFECTIOUS DISEASE RISK OF TRANSFUSION AND IMPROVEMENT AFTER CENTRALIZATION
TURN AROUND TIME (TAT) BLOOD SERVICES
EMERGENCY BLOOD TRANSFUSION SERVICES DURING LUSHAN EARTHQUAKE RESCUE, CHINA, 2013
CHANGES IN FFP TRANSFUSION PRACTICE AFTER IMPLEMENTATION OF NEW GUIDELINES IN A HOSPITAL IN SAUDI ARABIA
BLOOD INVENTORY MANAGEMENT IN A TERTIARY CARE HOSPITAL
BLOOD REQUISITION FORM - A KEY COMPONENT OF BLOOD SUPPLY CHAIN
THE STATUS OF THE KOREA BLOOD INVENTORY MONITORING SYSTEM, 2009-2012
BLOOD UTILIZATION FOR CHILDHOOD CANCER PATIENTS AT SARDJITO HOSPITAL YOGYAKARTA INDONESIA
CURRENT STATE AND PROSPECTS OF THE BLOOD SERVICE OF THE REPUBLIC OF KAZAKHSTAN
ANALYSIS OF UNUSED RED CELL CONCENTRATES EXCEEDING THE 4 H RETURN LIMIT AT HOSPITAL SULTAN HAJI AHMAD SHAH, TEMERLOH PAHANG
APPLICATION OF LEAN SIX SIGMA TO OPTIMIZE THE TIME FOR DISPATCHING NEW DONORS’ BLOOD SAMPLE TUBES TO GROUPING AND LABELING LABORATORY
RAISING THE BAR -REGULATION WITH ACCREDITATION
COMPARISON OF TWO HAEMOGLOBIN ESTIMATION TECHNIQUES; WHAT IS BEST FOR SRI LANKA
BLOOD UTILIZATION PATTERN IN SARDJITO GENERAL HOSPITAL BLOOD BANK,YOGYAKARTA, INDONESIA: ONE YEAR RETROSPECTIVE REVIEW
IDENTIFICATION OF THE TYPES OF PREANALYTICAL ERRORS OF BLOOD SAMPLES HANDLED IN THE TRANSFUSION MEDICINE LABORATORY OF A UNIVERSITY HOSPITAL IN NORTHEASTERN MALAYSIA
QUALITY ASSESSMENT OF RANDOM PLATELET CONCENTRATES: EXPERIENCE OF A TERTIARY CENTRE IN EASTCOAST OF MALAYSIA
SITE MASTER FILE FOR IRANIAN BLOOD ESTABLISHMENTS
PRE AND POST DONATION PREPAREDNESS FOR YOUNG DONORS
SHOULD DIABETES SCREENING FORM PART OF THE PREDONATION HEALTH ASSESSMENT OF BLOOD DONORS?
IDENTIFICATION OF CAUSES OF ANAEMIA AMONG BLOOD DONOR DEFERRALS IN A CENTRAL HOSPITAL BLOOD BANK IN KUANTAN, MALAYSIA
ANALYSIS OF THE EFFECTIVENESS OF AWARENESS PROGRAMS CONDUCTED BY NATIONAL BLOOD CENTER TO IMPROVE BLOOD COLLECTION DURING FESTIVE SEASON
SEROPREVALENCE OF TRANSFUSION TRANSMITTED DISEASES AMONG VOLUNTARY AND REPLACEMENT BLOOD DONORS -THE CHANGING SPECTRUM IN SOUTHERN INDIA
CALLBACK FOR HIV-POSITIVE DONORS BY PHONE CALL AND LETTER: INCREASED RETURN RATE OF POST-DONATION COUNSELLING AND REDUCTION IN DAYS TAKEN TO RETURN FOR COUNSELLING FROM DONATION DATE
AN INTERVENTIONAL STUDY TO ASSESS THE EFFECT OF AN EDUCATIONAL SESSION CONSISTING OF AN INTERACTIVE LECTURE ON KNOWLEDGE ABOUT BLOOD DONATION AMONG FIRST YEAR MEDICAL STUDENTS
REDUCTION FERRITIN SERUM LEVELS AND CARDIOVASCULAR RISK IN BLOOD DONORS WITH METABOLIC SYNDROME
WHAT FACTORS MOTIVATE DONORS TO DONATE PLATELETS?
ANALYSIS OF DONOR DEFERRAL PATTERN IN BLOOD BANK, DISTRICT GENERAL HOSPITAL, NEGOMBO, SRI LANKA
DONOR DEFERRAL: A CHALLENGE TO VOLUNTARY BLOOD DONATION IN A DEVELOPING COUNTRY
TEMPORARY DEFERRAL OF WHOLE BLOOD DONORS IN NATIONAL BLOOD CENTRE MALAYSIA FROM 2010 UNTIL 2012
KNOWLEDGE, ATTITUDE AND PRACTICE OF BLOOD DONATION AMONGST MEDICAL STUDENTS ACROSS INDIA
IS THERE DIFFERENT VIEW ON BLOOD DONATION FROM OUR TEENAGERS?
EFFECTIVENESS OF SHORT MESSAGE SERVICE IN RETAINING TEMPORARY DEFERRED WHOLE BLOOD DONOR DUE TO LOW HAEMOGLOBIN LEVEL
EFFECTS OF CATASTROPHES AND EXTRA ORDINARY EVENTS ON BLOOD DONATIONS IN EGYPT
FIRST TIME BLOOD DONORS IN NATIONAL BLOOD CENTRE KUALA LUMPUR MALAYSIA FROM 2010 UNTIL 2012
METABOLIC EFFECTS OF ACUTE INFUSION OF CITRATE DURING PLATELETPHERESIS IN NORMAL HEALTHY DONORS
INCREASED CD62P AND PAC 1 MARKERS WITH NORMAL PLATELET INDICES AMONG REGULAR PLATELETPHERESIS DONORS: A COMPARATIVE STUDY
AUTOMATED DOUBLE RED BLOOD CELL COLLECTION:HOW SAFE IS THE PROCESS IN SAUDI DONORS?
A REVIEW OF DIETARY HABIT AND KNOWEDGE LEVEL OF IRON DEFICIENCY AND SUPPLEMENT AMONGST CHINESE REGULAR BLOOD DONORS
FACTORS AFFECTING PLATELET YIELD DURING PLATELETPHERESIS DONATIONS
CONFIDENTIAL UNIT EXCLUSION IN THE ERA OF MOLECULAR TESTING: CONTRIBUTION TO BLOOD SAFETY AND PROFILE OF THE DONORS
UPP PROTOCOL FOR PLATELETS IN PLASMA UP TO SEVEN (7) DAY STORAGE AND CONCURRENTLY PLASMA COLLECTION WITH SETS WITH 17 G NEEDLE AT PLAUEN, GERMANY
NONINVASIVE PRE-DONATION HEMOGLOBIN SCREENING IN WHOLE BLOOD DONORS: IS IT TIME TO ADOPT IT?
HEMOLYSIS UPON PLATELETPHERESIS
BLOOD COLLECTION PROCESS CONTROL IN EGYPTIAN NBTS
QUALITY CONTROLS OF PRODUCTIVE PLASMAPHERESIS COLLECTED BY NIGALE NGL XJC 2000
P-063
COMPLIANCE OF DONORS TO PRODUCTIVE PLASMAPHERESIS PERFORMED BY NIGALE NGL XJC 2000
COMPARISON OF THE MEASURED DONOR PLATELET POSTCOUNT WITH THE MACHINE ESTIMATED VALUE ON THE NEW MCS+ LDP C5.1 PLATELET APHERESIS PROTOCOL
LEUKOCYTE REDUCTION OF DONOR BLOOD COMPONENTS IN RUSSIAN FEDERATION
EFFECT OF REQUEST LETTERS FOR APHERESIS PLASMA DONATION FOR HEPATITIS B IMMUNE GLOBULIN ON BEHAVIOR OF HIGH TITER DONORS
INFLUENCE OF DONOR VARIABLES ON THE PLATELET YIELD DURING PLATELET PHERESIS-EXPERIENCE OF 1100 PROCEDURES AT A TERTIARY-CARE HOSPITAL
PREVALENCE OF COELIAC DISEASE IN HEALTHY BLOOD DONORS: A STUDY FROM NORTH INDIA
WHOLE BLOOD DONOR RETURN RATES AFTER A VASOVAGAL REACTION IN SINGAPORE
P-071
ADVERSE DONOR REACTIONS AT NATIONAL BLOOD CENTRE KUALA LUMPUR
DONOR ADVERSE REACTIONS IN SAUDI BLOOD DONORS
THE PREVALENCE OF VASOVAGAL REACTIONS IN BLOOD DONORS AT BLOOD TRANSFUSION CENTER, FACULTY OF MEDICINE, KHON KAEN UNIVERSITY
ADVERSE REACTIONS DURING VOLUNTARY DONATION OF WHOLE BLOOD - FIRST TIME DONORS VERSES REGULAR DONORS WITHIN 1 YEAR EXPERIENCE
IMMEDIATE ADVERSE REACTIONS AMONG WHOLE BLOOD DONORS IN HOSPITAL SULTANAH BAHIYAH, KEDAH FROM JANUARY 2012 TO JUNE 2012
SCREENING OF KIDD NULL BLOOD DONORS WITH THE UREA LYSIS TEST IN SINGAPORE
IMMUNOGLOBULIN A DEFICIENCY IN SHANGHAI BLOOD DONORS: PREVALENCE, LABORATORY AND STRATEGIES
BOMBAY BLOOD GROUP IS TRULY A RARE ENTITY IN DELHI INDIA
THE QUALITY EVALUATION OF NON-PVC CONTAINERS FOR THE STORAGE OF PLATELETS
COMPARATIVE INVESTIGATION OF RESIDUAL NK-CELLS IN GAMMA-IRRADIATED AND IN PHOTOCHEMICALLY TREATED PLATELET CONCENTRATES
EVALUATION OF POLYPROPYLENE BLOOD BOX FOR TRANSPORTATION OF BLOOD COMPONENTS
NCI CAIRO UNIVERSITY EXPERIENCE IN AUTOMATED BLOOD COLLECTION
ACTIVITY OF COAGULATION FACTORS IN PLASMA PREPARED FROM DONATED WHOLE BLOOD WITHIN EIGHT (8) HOURS AND WHOLE BLOOD STORED OVERNIGHT
BUFFY COAT- DERIVED PLATELET CONCENTRATES: IN VITRO CHARACTERISTICS BETWEEN STORAGE IN PLATELET ADDITIVE SOLUTION AND IN PLASMA
VARIATION IN BLOOD COMPONENT STORAGE IN AN ANIMAL MODEL RELATED TO SINGLE NUCLEOTIDE VARIANTS IN SPECTRIN GENE SPNB1
A LOWER LEVEL OF SCD40L FOUND IN LEUKOREDUCED PLATELETS
A SMALL SCALE PROCESS VALIDATION FOR TERUMO TACSI WB SYSTEM WITH TACSI CRC AND PLT
THE USE OF CRYOPRECIPITATE AT THE NATIONAL HEART INSTITUTE, KUALA LUMPUR
A SIMPLE METHOD FOR ENRICHMENT OF A1-PROTEINASE INHIBITOR IN COHN FRACTION IV
PREPARATION OF IRRADIATED BLOOD PRODUCTS IN IRAN
ADEQUACY OF THE PLATELET AND CRYOPRECIPITATE PRODUCTION BY THE CLUSTER CENTERS OF THE NATIONAL BLOOD TRANSFUSION SERVICE OF SRILANKA
FEASIBILITY OF MANUAL PREPARATION OF WASHED PLATELET CONCENTRATES
POTENTIAL EFFECTIVENESS OF POTASSIUM ADSORPTION FILTER FOR PREVENTION OF HYPERKALEMIA DURING RAPID TRANSFUSION
A NEW ION-EXCHANGE ADSORBENTS PROCESS SPECIFICALLY DESIGNED TO REMOVE IMMUNOGLOBULIN A (IGA), IGM AND FACTOR XI/FXIA CONTAMINANTS FROM HUMAN PLASMA IGG
PREPARATION OF FACTOR VII CONCENTRATE BY IMMUNOAFFINITY CHROMATOGRAPHY
AN ATTEMPT TO PREPARE F IX BY A SIMPLE COLUMN CHROMATOGRAPHIC METHOD USING SEPHAROSE
POOLING OF INDIVIDUAL PF24 PLASMA DECREASES COAGULATION FACTOR ACTIVITY VARIATION
INACTIVATION OF PLASMODIUM FALCIPARUM IN ALL BLOOD COMPONENTS
INACTIVATION OF HIGH TITERS OF MULTIPLE PATHOGENS IN LARGE VOLUME DOUBLE DOSE PLATELET CONCENTRATES
AMOTOSALEN AND UVA LIGHT INACTIVATION OF PLATELET CONCENTRATES: IMPACT ON QUALITY AT DIFFERENT DAYS OF STORAGE
EVALUATION OF THE APPLICATION OF MIRASOL PRT SYSTEM TO BUFFY-COAT-DERIVED PLATELETS
EFFECTS OF PHOTOCHEMICAL THERAPIES (PSORALEN AND RIBOFLAVIN) ON APHERESISED PLATELET
FEASIBILITY STUDY FOR THE INTRODUCTION OF INTERCEPT PATHOGEN INACTIVATION TECHNOLOGY CONDUCTED AT THE NATIONAL BLOOD CENTRE, SRI LANKA
EVALUATION OF PATHOGEN INACTIVATION TREATMENT AS AN ALTERNATIVE TO GAMMA IRRADIATION FOR PREVENTING TA GVHD
EVALUATION OF PLASMA PROTEINS AFTER METHYLENE BLUE/LIGHT TREATMENT
REMOVAL OF VIRUCIDAL REAGENTS BY OIL EXTRACTION AND COLUMN CHROMATOGRAPHY IN THE PRODUCTION OF SAFE IGM-ENRICHED IMMUNOGLOBULIN
EVALUATION OF A NEW METHYLENE BLUE BASED DEVICE IN PATHOGEN REDUCTION OF PLASMA
DEVICE DESIGNATION FOR PATHOGEN REDUCTION IN HUMAN FRESH FROZEN PLASMA
HOXB4 COOPERATES WITH RUNX1 TO PROMOTE THE DEVELOPMENT OF HEMATOPOIETIC CELLS AT THE HEMOGENIC ENDOTHELIUM STAGE, IN VITRO
P-111
REPROGRAMMING HUMAN SOMATIC CELLS TOWARDS PLURIPOTENCY AND THEIR DIFFERENTIATION TO HEMATOPOIETIC STEM AND PROGENITOR CELLS
A SIX-YEAR's PILOT STUDY ON NUCLEIC ACID AMPLIFICATION TESTING FOR BLOOD SCREENING IN SHENZHEN CHINA
DETERMINATION OF THE SAMPLE POOL SIZE FOR A NUCLEIC ACID TEST THROUGH ITS ABILITY TO DETECT A LOW LEVEL OF VIRUS
RECIPIENT-TRIGGERED TRACEBACK IN KOREA FROM 2006 TO 2012
IMPLEMENTATION OF NUCLEIC ACID TESTING IN A GOVERNMENT BLOOD BANK SETTING IN NORTHERN INDIA
TREND AND SEROPREVALENCE IN TRANSFUSION TRANSMITTED INFECTIONS (TTI) AMONG BLOOD DONORS IN NATIONAL BLOOD CENTER, KUALA LUMPUR (NBCKL)
DECREASED SENSITIVITY BY MINI POOL NUCLEIC ACID TECHNOLOGY TESTING FOR HEPATITIS B VIRUS DETECTION
ID-NAT TESTING AND THE BENEFIT OF USER ALGORITHM IN A STAND-ALONE INDIAN BLOOD BANK
P-120
NUCLEIC ACID TESTING IN INDONESIA IN A HIGH HEPATITIS B VIRUS PREVALENCE COUNTRY
BLOOD SAFETY ASSURED THROUGH SENSITIVE SEROLOGY AND INDIVIDUAL DONATION-NUCLEIC ACID TECHNOLOGY TESTING AT A STAND-ALONE BLOOD BANK IN INDIA
NEGATIVE GREY ZONE IN SEROLOGICAL SCREENING TESTS OF DONORS: THE EXPERIENCE OF THE TERNI IMMUNOHEMATOLOGY AND TRANSFUSION SERVICE (SIT)
PREVALENCE OF VIRAL INFECTIONS IN THE DONOR POPULATION AT THE TERNI IMMUNOHEMATOLOGY AND TRANSFUSION SERVICE (SIT) IN THE THREE-YEAR PERIOD 2010-2012
SETTING QUALITY CONTROL LIMITS USING HISTORICAL DATA FOR SEROLOGICAL ASSAYS USED FOR SCREENING BLOOD DONATIONS
EVALUATION OF SCREENING AND CONFIRMATORY SEROLOGICAL ASSAYS IN BLOOD DONORS IN SOUTHERN ITALY
IMPORTANCE OF BLOOD SCREENING BY NUCLEIC ACID TESTING WITH A REPEAT TESTING ALGORITHM IN HEPATITIS C AND B VIRUS HIGH-PREVALENCE REGION
USER EXPERIENCE WITH THE PROCLEIX PANTHER SYSTEM FOR NUCLEIC ACID TESTING
CLINICAL SENSITIVITY AND SPECIFICITY COMPARISON OF PROCLEIX®ULTRIO® ASSAY AND PROCLEIX® ULTRIO PLUS® ASSAY IN INDIVIDUAL WHOLE BLOOD DONORS FROM CHINA
A RETROSPECTIVE STUDY TO DETERMINE IF THE SAMPLE TO CUT-OFF VALUE OF NUCLEIC ACID TESTING (NAT) CAN BE USED TO IMPROVE THE EFFICIENCY OF WPBTS NAT ALGORITHM
EVALUATION OF THE PROCLEIX® ULTRIO PLUS ASSAY ON AUTOMATED PROCLEIX® TIGRIS® SYSTEM
EVALUATION OF THE PROCLEIX® ULTRIO PLUS® ASSAY IN CHINESE BLOOD DONORS WITH POOLING ALGORITHM
A CASE STUDY: DISCORDANT RESULTS BETWEEN NAT AND SEROLOGY INDICATING CONTAMINATION OF SAMPLE AND ITS SUBSEQUENT RESOLUTION
P-134
TRANSFUSION TRANSMISSIBLE INFECTIONS (TTI) AWARENESS AMONG BLOOD DONORS IN A TERTIARY MEDICAL CENTER: AN OPEN LABEL RANDOMIZED TRIAL COMPARING TTI AWARENESS VIDEO VS STANDARD VERBAL EDUCATION
SYPHILIS SCREENING OF DONATED BLOOD BY ELISA VS RPR METHOD CONFIRMED BY TPHA
ADVERSE EFFECTS AND INCIDENCE OF TRANSFUSION TRANSMITTED INFECTIONS IN CHILDREN BORN AFTER 2000 AND MANAGED AT THE PAEDIATRIC HAEMOPHILIA CLINIC IN LADY RIDGEWAY HOSPITAL SRI LANKA
THE EVALUATION OF HHV-8 AMONG CORD BLOOD DONORS BY REAL TIME PCR
ENHANCED DETECTION OF HBV-DNA BY A MORE SENSITIVE TMA ASSAY VERSION (IN A REVISED TESTING ALGORITHM) DESPITE LOWER PREVALENCE OF HBSAG IN MALAYSIAN BLOOD DONORS
COMPARISON STUDY BETWEEN PROCLEIX ULTRIO AND ULTRIO PLUS ASSAY
HEPATITIS B CORE ANTIBODY (ANTI-HBC) PREVALENCE IN THE HEPATITIS B VIRUS VACCINATED BLOOD DONORS IN MALAYSIA
THE IMPACT OF NUCLEIC ACID TESTING (NAT) IN THE DETECTION OF OCCULT HEPATITIS B INFECTION IN A BLOOD DONOR POPULATION IN INDIA
HBV SCREENING POSITIVE RATE AND THE ASSOCIATING FACTORS IN BLOOD DONATION IN 2011, NATIONAL BLOOD CENTER, MYANMAR
EVALUATION OF LIAISON XL AND MUREX ELISA FOR THE NATURALLY- MUTATED HBSAG DETECTION
HEPATITIS B VIRUS INFECTION AMONG THE DONORS OF BLOOD CENTER OF ZHEJIANG PROVINCE IN CHINA
OCCULT HEPATITIS B INFECTION IN ANTI-HEPATITIS B CORE (ANTI-HBC) SEROPOSITIVE BLOOD DONORS: EXPERIENCE FROM TERTIARY CARE HOSPITAL IN SAUDI ARABIA
FREQUENCY OF HEPATITIS B VIRUS DNA IN ANTI-HBC POSITIVE, HBSAG NEGATIVE BLOOD DONORS
P-148
OCCUIT HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS
THE TREND OF HBV PREVALENCE AMONG FIRST TIME BLOOD DONORS REFERRED TO FARS BLOOD TRANSFUSION SERVICE (8 YEARS EXPERIENCE)
LACK OF OCCULT HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS IN REGION WITH HIGH PREVALENCE OF HBV IN THE EAST OF IRAN (SISTAN-O-BALUCHISTAN)
CHARACTERIZATION OF HEPATITIS C VIRUS GENOTYPE AMONG BLOOD DONORS AT THE BLOOD CENTRE OF ZHEJIANG PROVINCE IN CHINA
SEROPREVALENCE OF HEPATITIS C VIRUS AMONG BLOOD DONORS IN ORAN, ALGERIA: FROM 2009 TO 2012
HIV-1 CIRCULATING AMONG BLOOD DONORS IN JAPAN: PRESENT AND PAST
CHARACTERIZATION OF HIV NAT YIELDS DETECTED FROM DONORS DONATED AT NATIONAL BLOOD CENTRE, KUALA LUMPUR
SEROPREVALENCE OF HIV INFECTION AMONG BLOOD DONORS IN NORTHEASTERN TEACHING HOSPITAL
THE FREQUENCY OF TWO CHEMOKINE RECEPTOR GENE CCR5 POLYMORPHISMS (CCR5Δ32 AND CCR5-M303) IN IRANIAN POPULATION
COMPARISON TWO METHODS OF ENZYME IMMUNOASSAY (EIAS) AND CHEMILUMINESCENCE (CLIAS) FOR HIV SCREENING
SYPHILIS SCREENING AT THE TURIN HEMOCOMPONENTS PRODUCTION AND VALIDATION CENTRE (CPVE)
ASSESSMENT BIOFILM FORMATION AND DESICCATION RESISTANT ABILITY OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII
PERFORMANCE EVALUATION OF ARCHITECT SYPHILIS TP ON ARCHITECT I6000 ANALYZERS
OXIDATIVE STRESS IN CHAGAS DISEASE
PREVALENCE OF ANTIBODY POSITIVE BLOOD DONORS - EXPERIENCE FROM A TEACHING HOSPITAL IN CENTRAL SAUDI ARABIA
PREVALENCE OF MOSQUITO-BORNE VIRAL INFECTION (DENGUE FEVER, JAPANESE ENCEPHALITIS, AND CHIKUNGUNYA FEVER) AMONG BLOOD DONORS IN LAO PDR
PREVALENCE OF HTLV 1/2 AMONG BLOOD DONORS IN THAILAND
ACTIVE HERPES VIRUSES IN BLOOD DONORS ARE HAZARD FOR IMMUNOSUPPRESSED PATIENTS
SEROLOGICAL AND MOLECULAR STUDY OF HEPATITIS E VIRUS INFECTION FROM BLOOD DONORS IN SOUTHEAST CHINA
THE DEL DILEMMA - SHOULD WE DO ANYTHING ABOUT IT?
AUTOIMMUNE HAEMOLYTIC ANAEMIA DUE TO IGA AUTOC + D ANTIBODIES
THE INTERACTIVE KINETICS OF PROPHYLACTIC RH IMMUNE GLOBULIN WITH WEAK D MATERNAL AND RH POSITIVE FETAL RED CELLS
DETECTION OF ANTIBODIES TO GP.MUR IN TAIWAN AND CORRELATION WITH KODECYTES BEARING MUT, MUR, HIL AND TSEN ANTIGENS
AUTO ANTI-RH51 (MAR) LIKE AUTOANTIBODIES
LIMITED PHENOTYPE (RH AND KELL) MATCHING FOR SICKLE CELL DISEASE AND THALASSEMIC PATIENTS: EXPERIENCE AT A UNIVERSITY HOSPITAL IN SAUDI ARABIA
IN-HOUSE PREPARATION OF LECTIN PANEL AND DETECTION OF TN POLYAGGLUTINATION
FREQUENCY OF HIGH TITRE ANTI-A/B IN THE HONG KONG BLOOD DONOR POPULATION
RED CELL ALLOIMMUNIZATION IN PATIENTS UNDERGOING LIVING DONOR LIVER TRANSPLANTATION
COMPARISON OF ABO ANTIBODY TITER ACCORDING TO METHOD USED
IMMUNE RESPONSE OF M AND N ANTIGENS AFTER INJECTION OF IRRADIATED AND NON-IRRADIATED RED CELLS
EVALUATION OF FREQUENCIES OF CLINICALLY SIGNIFICANT MINOR BLOOD GROUP ANTIGENS IN THE NORTH INDIAN DONOR POPULATION
SEVERE FETAL HEMOLYTIC DISEASE CAUSED BY ANTI-E AND ANTI-C ANTIBODIES IN A D+ FEMALE: A CASE REPORT
ANTI-M ANTIBODIES DETECTED AT 37°C: A CASE SERIES
RBC ALLOANTIBODIES IN PATIENTS: EXPERIENCE OF DETECTING AND PROVIDING COMPATIBLE ANTIGEN NEGATIVE RED CELL UNITS IN A TERTIARY CARE CENTRE IN INDIA
A PILOT STUDY ON THE USE OF COMMERCIALLY PREPARED RED BLOOD CELLS IN THE ABSORPTION OF RED CELL ANTIBODIES
P-183
PREVALENCE OF ANTI-MIA ANTIBODY IN A TEACHING HOSPITAL ON EAST COAST OF MALAYSIA
RESOLUTION OF ABO DISCREPANCIES
ASSESSMENT OF RHESUS AND KELL BLOOD GROUP ANTIGENS, PHENOTYPES AND THEIR ALLELIC FREQUENCIES IN NORTH INDIAN BLOOD DONORS
FACTORS ASSOCIATED WITH INCREASED CUMULATIVE INCIDENCE OF RED CELL ALLOIMMUNIZATION AMONG TRANSFUSED ADULT THALASSEMIA PATIENTS
ACUTE HEMOLYTIC TRANSFUSION REACTION ASSOCIATED WITH ANTI-LEB ANTIBODY
ANTIBODY PREVALENCE TO RBC ANTIGENS IN HEALTHY VOLUNTARY BLOOD DONORS IN INDIA
AUTO IMMUNE HAEMOLYTIC ANAEMIA AFTER DPT VACCINATION IN A 4 MONTH OLD FEMALE INFANT - A CASE REPORT
SEROLOGICAL CONFIRMATION OF A GROUP O H-DEFICIENT SECRETOR PARA-BOMBAY DONOR
RARE ‘B’ SUBGROUP IN A PATIENT WITH DRUG INDUCED AUTOANTIBODY: A CASE REPORT
P-193
DAT NEGATIVE SEVERE DHTR IN A PATIENT WITH MULTIPLE ALLOANTIBODIES
PREVALENCE OF UNEXPECTED ANTIBODIES IN BLOOD DONORS IN NORTHEAST THAILAND
IRREGULAR ANTIBODIES IN PATIENTS OF SRINAGARIND HOSPITAL, THAILAND
EVALUATION OF A NOVEL SEROLOGY-BASED PLATFORM FOR SIMULTANEOUS BLOOD GROUP ANTIBODY IDENTIFICATION AND ANTIGEN TYPING (PROJECT MOSAIQTM)
JK NULL ALLELES ACCOUNTING FOR JK(A-B-) PHENOTYPE IN JAPANESE
P-199
LABORATORY-DEVELOPED MULTIPLEX SUSPENSION ARRAY FOR BLOOD GROUP GENOTYPING
ALTERED EXPRESSION OF A1 ANTIGEN IN ACUTE MYELOID LEUKEMIA
IDENTIFICATION OF RHESUS DEL GENOTYPE IN MALAY BLOOD DONOR AND ITS IMPLICATION IN TRANSFUSION MEDICINE
SOLUBLE OR IMMOBILIZED TISSUE FACTOR IN VON WILLEBRAND FACTOR-DEPENDENT MURAL THROMBUS FORMATION UNDER WHOLE BLOOD FLOW CONDITIONS
THE DETECTION OF ANTI-NAKA ANTIBODIES BY THE USE OF CD36 TRANSFECTED CELLS: COMPARISON WITH OTHER METHODS
TYPE II CD36 DEFICIENCY ON PLATELETS IS NOT DECIDED BY THE CD36 GENE ONLY
DETECTION AND IDENTIFICATION OF PLATELET ALLOANTIBODIES BY A MODIFIED ANTIGEN CAPTURE ELISA (MACE-1&2) AND ITS CORRELATION TO PLATELET REFRACTORINESS IN MULTI PLATELET CONCENTRATE TRANSFUSED PATIENTS
ESTABLISHMENT OF REFERENCE SYSTEM FOR HUMAN PLATELET ANTIGEN GENOTYPING
HUMAN PLATELET ANTIGEN GENOTYPING USING A MULTIPLEX SINGLE-BASE PRIMER EXTENSION REACTION IN KOREANS
MAIPA VS MODIFIED RAPID MAIPA ASSAY IN NATIONAL BLOOD CENTRE MALAYSIA
EVALUATION OF PLATELET CROSSMATCHING IN MANAGEMENT OF PATIENTS WITH PLATELET REFRACTORINESS
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO HPA-1A ANTIBODIES: A CASE REPORT
MITOCHONDRIAL PERMEABILITY TRANSITION PORE REGULATES PLATELET GPIBα ECTODOMAIN SHEDDING
FCGR3B GENE DUPLICATION AND DELETION COMMON IN THE TAIWANESE POPULATION
FULL LENGTH NUCLEOTIDE SEQUENCE OF SLC44A2 ALLELES ENCODING HUMAN NEUTROPHIL ANTIGEN-3 (HNA-3) IN AFRICAN AMERICANS AND CAUCASIANS
GENOTYPE FREQUENCY OF HUMAN NEUTROPHIL ANTIGEN-3 (HNA-3) POLYMORPHISM IN THE JIANGSU HAN CHINESE POPULATION
ESTABLISHMENT OF GENOTYPING METHOD FOR HUMAN NEUTROPHIL ANTIGEN OF HNA-3 SYSTEM BY PCR-SBT
MANAGEMENT OF HDN's PREVENTION IN ASL CASERTA
POLYTRANSFUSION MAY LEAD TO ALLOANTIBODY FORMATION EVEN IN THE NEONATAL PERIOD
SPLITTING OF BLOOD PRODUCTS FOR THE PREVENTION OF MISTRANSFUSION IN PEDIATRIC PATIENTS
ESTIMATE OF NORMAL VALUES OF HAEMOSTASIS IN NEONATAL PERIOD
THERAPEUTIC EFFICACY AND SAFETY OF PLASMA EXCHANGE IN PEDIATRIC HEMOLYTIC UREMIC SYNDROME (HUS) PATIENTS
MONITORING EFFICACY OF THERAPEUTIC PLASMA EXCHANGE DEPLETING ANTI-A AND ANTI-B TITRE IN ABO INCOMPATIBLE SOLID ORGAN TRANSPLANTATION
DESCRIPTIVE STUDY ON RED BLOOD CELLS TRANSFUSION PRACTICE IN OBSTETRIC PATIENTS
THE CHARACTERISTICS OF RED BLOOD CELL UTILIZATION IN THREE CHINESE HOSPITALS
EVALUATION OF THE CURRENT TRANSFUSION PRACTICES IN MANAGING THE DENGUE PATIENTS IN AN ENDEMIC COUNTRY
RED BLOOD CELL STORAGE IS NOT ASSOCIATED WITH MORTALITY AND LENGTH OF STAY AFTER CARDIAC SURGERY
P-227
P-228
CRYOPRECIPITATE IN HOSPITAL KUALA LUMPUR: A PRACTICE REVIEW
USAGE OF FRESH FROZEN PLASMA (FFP) IN HOSPITAL KUALA LUMPUR (HKL): A TRANSFUSION PRACTICE REVIEW
APPROPRIATE PRESCRIPTION OF BLOOD IN A TERTIARY HOSPITAL IN THE CITY OF YAOUNDE, AN UPDATE FROM PREVIOUS STUDIES
TRANSFUSION SUPPORT IN LIVER TRANSPLANTATION - A REVIEW OF THE INITIAL 70 CASES
PERIOPERATIVE MANAGEMENT OF HEMOSTASIS IN A NEUROSURGERY PATIENT BY THROMBOELASTOGRAPHY
DELAYED HAEMOLYTIC TRANSFUSION REACTION IN SICKLE CELL DISEASE - A LIFE-THREATENING COMPLICATION
ADOPTING A REVISED SYSTEM FOR CLASSIFICATION OF TRANSFUSION REACTIONS: EXPERIENCE OF A TERTIARY CARE HOSPITAL FROM INDIA
AN AUDIT ON THE IMPACT OF NATIONAL CLINICAL BLOOD TRANSFUSION GUIDELINES ON REDUCING INAPPROPRIATE RED CELL AND PLASMA REQUESTS IN SINGAPORE
ERRORS IN TRANSFUSION PROCESS: A CLINICAL AUDIT AND IMPLEMENTATION OF REMEDIAL ACTIONS
LOOKBACK PROGRAMME: EXPERIENCE AT THE NATIONAL HEART INSTITUTE, KUALA LUMPUR
RECENT IMPROVEMENTS IN HAEMOVIGILANCE SYSYTEM OF SRI LANKA
FACTORS INFLUENCING THE TRANSFUSION REQUIREMENT IN CORONARY ARTERY BYPASS GRAFT PATIENTS
NEAR MISS EVENTS IN MALAYSIA 2010-2012
REGENERATED SILK FIBROIN FILM MODIFIED BY LIF TRANSGENIC FEEDER CELLS PROMOTES EX VIVO EXPANSION OF UMBILICAL CORD BLOOD HSC
EXPANSION OF CORD BLOOD HEMATOPOIETIC STEM CELLS IN CO-CULTURE OF MESENCHYMAL STEM CELLS USING TEPA
ALDEHYDE DEHYDROGENASE-BRIGHT CELLS OF CORD BLOOD SHOWED HIGHER CORRELATION WITH COLONY FORMING UNIT-GRANULOCYTE/MACROPHAGE THAN CD34+ CELLS
CULTURES OF HUMAN INDUCED PLURIPOTENT STEM (HIPS) CELLS ON MATRIGEL MATRIX WITH CONDITIONAL MEDIA
CYTOGENTIC ANALYSIS OF HUMAN DERMAL FIBROBLASTS (HDFS) CELLS IN EARLY AND LATE PASSAGES USING BOTH KARYOTYPING AND COMET ASSAY TECHNIQUES
COMPARATIVE ANALYSIS BETWEEN CORD BLOOD FROM FREEZING BAG AND FROM SEGMENT AFTER THAWING: CORD BLOOD FROM SEGMENT WOULD SERVE AS A SOURCE FOR QUALITY EVALUATION OF THE CRYOPRESERVED CORD BLOOD
DEVELOPMENT OF NATIONAL CORD BLOOD BANK, NATIONAL BLOOD CENTRE
P-249
CHARACTERIZATION OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS AFTER TREATMENT WITH EVEROLIMUS, A DRUG TARGET-BASED
REVISION OF THE HUMAN HEMATOPOIETIC TREE: GRANULOCYTE SUBTYPES DERIVE FROM DISTINCT HEMATOPOIETIC LINEAGES
P-252
STUDY OF CURRENT MAINTENANCE AND AFFECTS OF ENVIRONMENTAL AND CLIMATE CHANGES ON BLOOD BANK REFRIGERATORS PERFORMANCE AT IRANIAN BLOOD TRANSFUSION CENTERS
P-254
HLA ANTIBODY IN PLATELET APHERESIS DONORS IN NORTHEAST THAILAND
THE STUDY OF HLA ALLOIMMUNISATION IN CHINESE BLOOD DONORS
ASSESSMENT OF FREQUENCY AND SPECIFICITIES OF ANTI-HLA ANTIBODIES OF SRI-LANKAN POPULATION
LABELLING OF AGAROSE GEL FOR ENSURING TRACEABILITY: A COST EFFECTIVE AND SIMPLE METHOD
HLA SEQUENCE BASED TYPING: EXPERIENCE FROM PUBLIC CORD BLOOD BANK, MALAYSIA
IMPLEMENTING SBT IN OUR HLA LABORATORY - A COMPARISON OF SBT KITS
HYPERTENSION AND HLA-A MISMATCHING ARE ASSOCIATED WITH RESTARTING DIALYSIS IN KIDNEY TRANSPLANTATION
ASSOCIATION BETWEEN HUMAN LEUKOCYTE ANTIGEN CLASS I AND II ALLELES AND HEPATITIS C VIRUS INFECTION IN HIGH-RISK HEMODIALYSIS PATIENTS AWAITING KIDNEY TRANSPLANTATION
DEGREE OF HLA HAPLOTYPE MATCHING OF KIDNEY DONORS WITH REFERENCE TO THEIR RELATIONSHIP WITH THE PATIENTS
CORRELATION OF CDC RESULTS AND DSA PERFORMED ON THE LUMINEX PLATFORM: DERIVING CUT-OFF MFI FOR PREDICTION OF POSITIVE DONOR SPECIFIC CROSSMATCH - A PILOT STUDY
PREDICTIVE VALUE OF PNEUMOCOCCAL AND HLA ANTIBODIES ON KIDNEY TRANSPLANT OUTCOME
THE RELATION OF HLA-DRB1 AND OUTCOME OF ALLOGRAFT IN IRANIAN KIDNEY TRANSPLANT RECIPIENTS